Product Information
DEXTROAMPHETAMINE ER 5 MG CAP is a generic product labeled by Actavis Pharma, Inc., priced at $1.1006 per EA under NDC 45963030309. Its NADAC has been published 633 times since Aug 20, 2014.
FDA first approved this application on Nov 30, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Actavis Pharma, Inc.NDC
45963030309
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DEXTROAMPHETAMINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA203901FDA Approved
11/30/2012
TE Code
AB
On Market Since
6/19/2014
Pharmacological Classes
Price Statistics
The NADAC for DEXTROAMPHETAMINE ER 5 MG CAP has been published 633 times since Aug 20, 2014, and over the history we have for it it has declined 59.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.1006 per EA |
|---|---|
| All-time high | $2.9203 (May 13, 2015) |
| All-time low | $0.6951 (Jun 19, 2024) |
| 52-week high | $1.3521 |
| 52-week low | $0.8900 |
| Median price | $1.2713 |
| Average price | $1.4986 |
| Largest weekly change | +62.1% (Jun 21, 2023) |
| Weeks tracked | 633 |
| Tracking since | Aug 20, 2014 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the dextroamphetamine sulfate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Actavis Pharma, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
dextroamphetamine sulfate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Central Nervous System Stimulant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DEXTROAMPHETAMINE ER 5 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMPHETAMINE ER 5 MG CAP, manufactured by Actavis Pharma, Inc., is $1.1006 per EA (NDC 45963030309), effective Sep 30, 2026.
How has the price of DEXTROAMPHETAMINE ER 5 MG CAP changed over time?
Over the history we have for it, the NADAC for DEXTROAMPHETAMINE ER 5 MG CAP has declined 59.0%. It has been tracked across 633 weekly CMS publications since Aug 20, 2014.
What are the highest and lowest recorded NADAC prices for DEXTROAMPHETAMINE ER 5 MG CAP?
Since Aug 20, 2014, the NADAC for DEXTROAMPHETAMINE ER 5 MG CAP has ranged from a low of $0.6951 (Jun 19, 2024) to a high of $2.9203 (May 13, 2015), with a median of $1.2713 per EA.
Are there cheaper alternatives to DEXTROAMPHETAMINE ER 5 MG CAP?
No other NADAC-published product currently shares the active ingredient and strength of DEXTROAMPHETAMINE ER 5 MG CAP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DEXTROAMPHETAMINE ER 5 MG CAP?
DEXTROAMPHETAMINE ER 5 MG CAP (NDC 45963030309) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.